Arkuda Reels in Another $64M to Disrupt Neurodegenerative Di

Arkuda seeks to disrupt the usual progression of neurodegenerative disease with medicines developed by applying cutting-edge knowledge from the domains of lysosomal and microglial biology.

Related Keywords

Boston , Massachusetts , United States , Raymondj Kelleher , Gerhard Koenig , Arkuda Therapeuticsannounced , Eli Lilly , Heather Preston , Atlas Venture , Tekla Capital Management , Mission Biocapital , Boston Financial District , Cormorant Asset Management , Venture Partners , Surveyor Capital , Pfizer Ventures , Arkuda Board , Resume , Careers , Rkuda Reels In Another 64m To Disrupt Neurodegenerative Disease Treatment , Iospace , Advice ,